INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›science›Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization
science

Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization

By Info60 World Desk•Summary of reporting by Businesswire•Sep 23, 2026•0 views•
Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced the appointment of Bo Cumbo to its Board of Directors. Concurrent with Mr. Cumbo’s appointment, Edward Kaye, M.D., has retired
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Autonomous Mobile Robots Market Forecasts Growth from $2.39B (2025) to $7.07B by 2032, Profiling Locus Robotics, Omron, Mobile Industrial Robots, Fetch Robotics & Geek+

Globenewswire_fr

Automotive Lead-Acid Battery Market Forecasts Growth from $31.08B (2026) to $37.45B by 2033, Profiling Clarios, Exide, GS Yuasa, East Penn & EnerSys

Globenewswire_fr

Quality Management System Software Market Forecasts Growth from $11.73B (2026) to $20.43B by 2031, Profiling Veeva Systems, Siemens, PTC, SAP, Oracle & 15 Others

Globenewswire_fr

Event Management Software Market Forecasts Growth from $18.6B (2026) to $36.8B by 2031, Profiling Cvent, Eventbrite, Zoom, Bizzabo, RingCentral & Others

Globenewswire_fr

Medical Equipment Cooling Market Forecasts Growth from $0.63B (2026) to $0.82B by 2031, Profiling Parker Hannifin, Daikin, Thermo Fisher & Boyd Corporation

Globenewswire_fr

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!